Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

15.6K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipid nanoparticle GM-CSF replacement for autoimmune pulmonary alveolar proteinosis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Soluble Antigen Arrays Alter the Response of Epitope-Specific Diabetogenic T Cells.

ACS applied bio materials·2026
Same author

Soluble Antigen Array Displaying Proinsulin(F25D) Selectively Targets Anti-insulin B Cells without Hormonal Effects.

Molecular pharmaceutics·2026
Same author

Engineered Nonhormonal, Cationic Proinsulin Variants Prolong Lymphatic Drainage.

Molecular pharmaceutics·2025
Same author

Magnetically Actuated Cell Culture Platform for Controlling High-Throughput Cyclic Strain.

Macromolecular bioscience·2025
Same author

Nanoparticle delivery of a prodrug-activating bacterial enzyme leads to anti-tumor responses.

Nature communications·2025

Related Experiment Video

Updated: Oct 7, 2025

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
09:07

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

11.0K

Brain Homogenate Decoys for Antigen-Specific Cell Amplification.

J Daniel Griffin1,2, Sebastian G Huayamares1, Towne R Walston3

  • 1Bioengineering Graduate Program, University of Kansas, Lawrence, Kansas 66045, United States.

ACS Applied Bio Materials
|January 11, 2022
PubMed
Summary

Researchers created novel biomaterials to amplify rare multiple sclerosis biomarkers. These antigen-specific materials mimic the central nervous system, aiding in disease monitoring and understanding autoimmunity.

Keywords:
antigen-specific immune decoyautoimmunitybiomaterialexperimental autoimmune encephalomyelitis (EAE)immunotherapy

More Related Videos

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

9.9K
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

15.6K

Related Experiment Videos

Last Updated: Oct 7, 2025

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
09:07

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

11.0K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

9.9K
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

15.6K

Area of Science:

  • Biomaterials Science
  • Neuroimmunology
  • Autoimmunity Research

Background:

  • Multiple sclerosis (MS) is a complex and heterogeneous neurological disease.
  • Current methods for monitoring MS often lack sensitivity due to rare blood-based biomarkers.
  • There is a critical need for advanced tools to effectively track disease progression in individuals.

Purpose of the Study:

  • To develop novel antigen-specific biomaterials capable of replicating the central nervous system (CNS) microenvironment.
  • To create a system for amplifying scarce multiple sclerosis biomarkers.
  • To investigate the potential of these biomaterials for monitoring MS and decoding human autoimmunity.

Main Methods:

  • Incorporation of mouse brain homogenate into a microporous gelatin methacrylate network.
  • Development of antigen-specific biomaterials designed to mimic the CNS niche.
  • Assessment of differential cellular stimulation and biomarker amplification within the biomaterial system.

Main Results:

  • The developed biomaterials successfully replicated aspects of the CNS niche.
  • Biomaterials containing primary tissue homogenate demonstrated differential cellular stimulation.
  • A marked amplification of disease-relevant, antigen-specific B cells was observed.

Conclusions:

  • Biomaterials incorporating primary tissue homogenate retain antigen specificity.
  • These novel biomaterials show promise as a tool for amplifying and detecting rare biomarkers.
  • The developed system may offer a valuable approach for decoding human autoimmunity, particularly in conditions like MS.